Stevan Shaw

2.1k total citations
43 papers, 1.4k citations indexed

About

Stevan Shaw is a scholar working on Immunology, Rheumatology and Dermatology. According to data from OpenAlex, Stevan Shaw has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 12 papers in Rheumatology and 8 papers in Dermatology. Recurrent topics in Stevan Shaw's work include Psoriasis: Treatment and Pathogenesis (17 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and T-cell and B-cell Immunology (6 papers). Stevan Shaw is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (17 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and T-cell and B-cell Immunology (6 papers). Stevan Shaw collaborates with scholars based in United Kingdom, United States and Belgium. Stevan Shaw's co-authors include Dominique Baeten, Sophie Glatt, Pavan Vajjah, Meryn Griffiths, Ruth Oliver, Foteini Strimenopoulou, Lucian Ionescu, Alastair D. G. Lawson, Terry Baker and H.A. Tilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Stevan Shaw

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stevan Shaw United Kingdom	21	749	350	338	202	187	43	1.4k
Dominique Talabot‐Ayer Switzerland	23	1.7k 2.3×	303 0.9×	330 1.0×	224 1.1×	641 3.4×	38	2.7k
Ruchi Upmanyu United Kingdom	10	243 0.3×	205 0.6×	66 0.2×	86 0.4×	139 0.7×	15	835
Michael Pike United Kingdom	24	111 0.1×	237 0.7×	88 0.3×	66 0.3×	459 2.5×	61	1.9k
Jill Donelan United States	15	438 0.6×	102 0.3×	146 0.4×	23 0.1×	299 1.6×	19	1.2k
C Craviotto Italy	10	173 0.2×	248 0.7×	155 0.5×	58 0.3×	89 0.5×	15	785
Ellen Goldmuntz United States	21	398 0.5×	157 0.4×	65 0.2×	291 1.4×	403 2.2×	53	1.6k
Gunther Neeck Germany	20	215 0.3×	352 1.0×	27 0.1×	92 0.5×	181 1.0×	37	1.1k
Carlo Avolio Italy	22	298 0.4×	263 0.8×	37 0.1×	108 0.5×	398 2.1×	75	1.8k
M. Braga Italy	19	86 0.1×	274 0.8×	201 0.6×	66 0.3×	211 1.1×	44	1.4k
Richard C. Chou United States	16	457 0.6×	178 0.5×	50 0.1×	75 0.4×	347 1.9×	29	1.2k

Countries citing papers authored by Stevan Shaw

Since Specialization

Citations

This map shows the geographic impact of Stevan Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stevan Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stevan Shaw more than expected).

Fields of papers citing papers by Stevan Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stevan Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stevan Shaw. The network helps show where Stevan Shaw may publish in the future.

Co-authorship network of co-authors of Stevan Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Stevan Shaw. A scholar is included among the top collaborators of Stevan Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stevan Shaw. Stevan Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cutcutache, Ioana, et al.. (2024). 52693 Normalization of molecular signatures associated with pruritis in plaque psoriasis correlate with itch resolution following bimekizumab treatment. Journal of the American Academy of Dermatology. 91(3). AB66–AB66. 1 indexed citations

Adams, Ralph, et al.. (2024). Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition. Journal of Investigative Dermatology. 144(11). 2581–2583.e2.

Cutcutache, Ioana, Andrew Skelton, Athanassios Kolivras, et al.. (2023). 187 Bimekizumab treatment in psoriasis patients: A mechanistic understanding of the durable clinical response. Journal of Investigative Dermatology. 143(11). S364–S364.

Cole, Suzanne, Nicole Yager, Hefin Rhys, et al.. (2023). Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease. Journal of Allergy and Clinical Immunology. 152(3). 783–798. 22 indexed citations

Glatt, Sophie, Gregor B. E. Jemec, Seth Forman, et al.. (2021). Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa. JAMA Dermatology. 157(11). 1279–1279. 112 indexed citations

Chen, Sijia, Iris C. Blijdorp, Leonieke van Mens, et al.. (2020). Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis. The Journal of Rheumatology. 47(11). 1606–1613. 14 indexed citations

Chen, Sijia, Ross A. Paveley, Elizabeth Stevens, et al.. (2020). Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. Journal of Autoimmunity. 111. 102435–102435. 26 indexed citations

Cole, Suzanne, Janine Murray, Catherine Simpson, et al.. (2020). Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling. Frontiers in Immunology. 11. 585134–585134. 52 indexed citations

Glatt, Sophie, Peter C. Taylor, Iain B. McInnes, et al.. (2019). Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study. Annals of the Rheumatic Diseases. 78(8). 1033–1040. 49 indexed citations

10.

Lightwood, Daniel, Kaushik Sarkar, Alison Turner, et al.. (2018). Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma. American Journal of Respiratory and Critical Care Medicine. 198(5). 610–619. 24 indexed citations

11.

Shah, Mittal, et al.. (2017). THU0060 T cell-derived IL-17A and IL-17F drive bone formation from human periosteal stem cells: implications for enthesophyte formation. Annals of the Rheumatic Diseases. 76. 221–221. 1 indexed citations

12.

Smallie, Timothy, et al.. (2017). 699 Dual IL-17A and IL-17F inhibition with bimekizumab provides evidence for IL-17F contribution to immune-mediated inflammatory skin response. Journal of Investigative Dermatology. 137(5). S120–S120. 5 indexed citations

13.

Glatt, Sophie, Dominique Baeten, Terry Baker, et al.. (2017). Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Annals of the Rheumatic Diseases. 77(4). 523–532. 204 indexed citations

14.

Gozzard, Neil, Daniel Lightwood, Kaushik Sarkar, et al.. (2017). Novel inhaled delivery of anti-IL-13 mAb (Fab fragment): preclinical efficacy in allergic asthma. PA4019–PA4019. 3 indexed citations

15.

Shaw, Stevan, Tim Bourne, Chris Meier, et al.. (2014). Discovery and characterization of olokizumab. mAbs. 6(3). 773–781. 70 indexed citations

16.

Smith, Emma, et al.. (2012). A humanised mouse model of cytokine release: Comparison of CD3-specific antibody fragments. Journal of Immunological Methods. 384(1-2). 33–42. 11 indexed citations

17.

Pedroza, Mesias, Daniel J. Schneider, Harry Karmouty‐Quintana, et al.. (2011). Interleukin-6 Contributes to Inflammation and Remodeling in a Model of Adenosine Mediated Lung Injury. PLoS ONE. 6(7). e22667–e22667. 90 indexed citations

18.

Foulkes, Roly & Stevan Shaw. (1992). The cardiodepressant and vasodepressant effects of tumour necrosis factor in rat isolated atrial and aortic tissues. British Journal of Pharmacology. 106(4). 942–947. 10 indexed citations

19.

Tilson, Hugh A., et al.. (1988). Radial-arm maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agents. Brain Research. 438(1-2). 83–94. 71 indexed citations

20.

Chakravarti, Sudip, et al.. (1988). A double‐blind dose‐finding study of rolipram in patients with major depressive disorder. Human Psychopharmacology Clinical and Experimental. 3(4). 275–280. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact